253 related articles for article (PubMed ID: 32686305)
1. The use of interval-compressed chemotherapy with the addition of vincristine, irinotecan, and temozolomide for pediatric patients with newly diagnosed desmoplastic small round cell tumor.
Liu KX; Collins NB; Greenzang KA; Furutani E; Campbell K; Groves A; Mullen EA; Shusterman S; Spidle J; Marcus KJ; Weil BR; Weldon CB; Frazier AL; Janeway KA; O'Neill AF; Mack JW; DuBois SG; Shulman DS
Pediatr Blood Cancer; 2020 Oct; 67(10):e28559. PubMed ID: 32686305
[TBL] [Abstract][Full Text] [Related]
2. Whole abdominopelvic intensity-modulated radiation therapy for desmoplastic small round cell tumor after surgery.
Pinnix CC; Fontanilla HP; Hayes-Jordan A; Subbiah V; Bilton SD; Chang EL; Grosshans DR; McAleer MF; Sulman EP; Woo SY; Anderson P; Green HL; Mahajan A
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):317-26. PubMed ID: 22104361
[TBL] [Abstract][Full Text] [Related]
3. Desmoplastic Small Round Cell Tumor Treated with Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy: Results of a Phase 2 Trial.
Hayes-Jordan AA; Coakley BA; Green HL; Xiao L; Fournier KF; Herzog CE; Ludwig JA; McAleer MF; Anderson PM; Huh WW
Ann Surg Oncol; 2018 Apr; 25(4):872-877. PubMed ID: 29383611
[TBL] [Abstract][Full Text] [Related]
4. Vincristine, irinotecan, and temozolomide treatment for refractory/relapsed pediatric solid tumors: A single center experience.
Büyükkapu Bay S; Kebudi R; Görgün O; Zülfikar B; Darendeliler E; Çakır FB
J Oncol Pharm Pract; 2019 Sep; 25(6):1343-1348. PubMed ID: 30080131
[TBL] [Abstract][Full Text] [Related]
5. Abdominal desmoplastic small round cell tumor: multimodal treatment combining chemotherapy, surgery, and radiotherapy is the best option.
Honoré C; Amroun K; Vilcot L; Mir O; Domont J; Terrier P; Le Cesne A; Le Péchoux C; Bonvalot S
Ann Surg Oncol; 2015 Apr; 22(4):1073-9. PubMed ID: 25300608
[TBL] [Abstract][Full Text] [Related]
6. The addition of cixutumumab or temozolomide to intensive multiagent chemotherapy is feasible but does not improve outcome for patients with metastatic rhabdomyosarcoma: A report from the Children's Oncology Group.
Malempati S; Weigel BJ; Chi YY; Tian J; Anderson JR; Parham DM; Teot LA; Rodeberg DA; Yock TI; Shulkin BL; Spunt SL; Meyer WH; Hawkins DS
Cancer; 2019 Jan; 125(2):290-297. PubMed ID: 30351457
[TBL] [Abstract][Full Text] [Related]
7. Irinotecan and vincristine for the treatment of refractory desmoplastic small round cell tumor in a developing country: a case report.
Ambar NBD; de Seixas Alves MT; Lederman HM; Abib S; Duarte AAB; Caran EM
J Med Case Rep; 2019 Mar; 13(1):77. PubMed ID: 30851735
[TBL] [Abstract][Full Text] [Related]
8. Randomized Phase II Trial of Vincristine-Irinotecan With or Without Temozolomide, in Children and Adults With Relapsed or Refractory Rhabdomyosarcoma: A European Paediatric Soft Tissue Sarcoma Study Group and Innovative Therapies for Children With Cancer Trial.
Defachelles AS; Bogart E; Casanova M; Merks JHM; Bisogno G; Calareso G; Gallego Melcon S; Gatz SA; Le Deley MC; McHugh K; Probst A; Rocourt N; van Rijn RR; Wheatley K; Minard-Colin V; Chisholm JC
J Clin Oncol; 2021 Sep; 39(27):2979-2990. PubMed ID: 34343032
[TBL] [Abstract][Full Text] [Related]
9. Desmoplastic Small Round Cell Tumor: Long-Term Complications After Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy.
Stiles ZE; Murphy AJ; Anghelescu DL; Brown CL; Davidoff AM; Dickson PV; Glazer ES; Bishop MW; Furman WL; Pappo AS; Lucas JT; Deneve JL
Ann Surg Oncol; 2020 Jan; 27(1):171-178. PubMed ID: 30963398
[TBL] [Abstract][Full Text] [Related]
10. VIncristine, irinotecan, and temozolomide in children and adolescents with relapsed rhabdomyosarcoma.
Setty BA; Stanek JR; Mascarenhas L; Miller A; Bagatell R; Okcu F; Nicholls L; Lysecki D; Gupta AA
Pediatr Blood Cancer; 2018 Jan; 65(1):. PubMed ID: 28748602
[TBL] [Abstract][Full Text] [Related]
11. Irinotecan-temozolomide with temsirolimus or dinutuximab in children with refractory or relapsed neuroblastoma (COG ANBL1221): an open-label, randomised, phase 2 trial.
Mody R; Naranjo A; Van Ryn C; Yu AL; London WB; Shulkin BL; Parisi MT; Servaes SE; Diccianni MB; Sondel PM; Bender JG; Maris JM; Park JR; Bagatell R
Lancet Oncol; 2017 Jul; 18(7):946-957. PubMed ID: 28549783
[TBL] [Abstract][Full Text] [Related]
12. Vincristine, irinotecan, and temozolomide in patients with relapsed and refractory Ewing sarcoma.
Raciborska A; Bilska K; Drabko K; Chaber R; Pogorzala M; Wyrobek E; Polczyńska K; Rogowska E; Rodriguez-Galindo C; Wozniak W
Pediatr Blood Cancer; 2013 Oct; 60(10):1621-5. PubMed ID: 23776128
[TBL] [Abstract][Full Text] [Related]
13. Can we cure patients with abdominal Desmoplastic Small Round Cell Tumor? Results of a retrospective multicentric study on 100 patients.
Honoré C; Delhorme JB; Nassif E; Faron M; Ferron G; Bompas E; Glehen O; Italiano A; Bertucci F; Orbach D; Pocard M; Quenet F; Blay JY; Carrere S; Chevreau C; Mir O; Le Cesne A;
Surg Oncol; 2019 Jun; 29():107-112. PubMed ID: 31196472
[TBL] [Abstract][Full Text] [Related]
14. Clinical Activity of Pazopanib in Patients with Advanced Desmoplastic Small Round Cell Tumor.
Menegaz BA; Cuglievan B; Benson J; Camacho P; Lamhamedi-Cherradi SE; Leung CH; Warneke CL; Huh W; Subbiah V; Benjamin RS; Patel S; Daw N; Hayes-Jordan A; Ludwig JA
Oncologist; 2018 Mar; 23(3):360-366. PubMed ID: 29212731
[TBL] [Abstract][Full Text] [Related]
15. A phase I trial of metformin in combination with vincristine, irinotecan, and temozolomide in children with relapsed or refractory solid and central nervous system tumors: A report from the national pediatric cancer foundation.
Metts JL; Trucco M; Weiser DA; Thompson P; Sandler E; Smith T; Crimella J; Sansil S; Thapa R; Fridley BL; Llosa N; Badgett T; Gorlick R; Reed D; Gill J
Cancer Med; 2023 Feb; 12(4):4270-4281. PubMed ID: 36151773
[TBL] [Abstract][Full Text] [Related]
16. Vincristine, Irinotecan, and Temozolomide as a Salvage Regimen for Relapsed or Refractory Sarcoma in Children and Young Adults.
Ju HY; Park M; Lee JA; Park HJ; Park SY; Kim JH; Kang HG; Yang HC; Park BK
Cancer Res Treat; 2022 Apr; 54(2):563-571. PubMed ID: 34126703
[TBL] [Abstract][Full Text] [Related]
17. Abdominal desmoplastic small round cell tumor without extraperitoneal metastases: Is there a benefit for HIPEC after macroscopically complete cytoreductive surgery?
Honoré C; Atallah V; Mir O; Orbach D; Ferron G; LePéchoux C; Delhorme JB; Philippe-Chomette P; Sarnacki S; Msika S; Terrier P; Glehen O; Martelli H; Minard-Colin V; Bertucci F; Blay JY; Bonvalot S; Elias D; LeCesne A; Sargos P;
PLoS One; 2017; 12(2):e0171639. PubMed ID: 28234908
[TBL] [Abstract][Full Text] [Related]
18. Intra-Abdominal Desmoplastic Small Round Cell Tumor (DSRCT) and the Role of Hyperthermic Intraperitoneal Chemotherapy (HIPEC): A Review.
Reijers SJM; Siew CCH; Kok NFM; Honoré C; van Houdt WJ
Curr Oncol; 2023 Mar; 30(4):3951-3963. PubMed ID: 37185412
[TBL] [Abstract][Full Text] [Related]
19. Reduced toxicity with intensity modulated radiation therapy (IMRT) for desmoplastic small round cell tumor (DSRCT): an update on the whole abdominopelvic radiation therapy (WAP-RT) experience.
Desai NB; Stein NF; LaQuaglia MP; Alektiar KM; Kushner BH; Modak S; Magnan HM; Goodman K; Wolden SL
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):e67-72. PubMed ID: 23084475
[TBL] [Abstract][Full Text] [Related]
20. Survival and toxicity following sequential multimodality treatment including whole abdominopelvic radiotherapy for patients with desmoplastic small round cell tumor.
Osborne EM; Briere TM; Hayes-Jordan A; Levy LB; Huh WW; Mahajan A; Anderson P; McAleer MF
Radiother Oncol; 2016 Apr; 119(1):40-4. PubMed ID: 26527430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
